Skip to content

Clinical trials

Phase 2 Pneumonia, Bacterial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pneumonia, Bacterial Phase: Phase 2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20091
20102
20131
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Cardeas Pharma1
Eagle Pharmaceuticals, Inc.1
Furiex Pharmaceuticals, Inc1
GlaxoSmithKline1
Hoffmann-La Roche1
National Heart, Lung, and Blood Institute (NHLBI)1
PriCara, Unit of Ortho-McNeil, Inc.1
University of Florida1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pneumonia, Bacterial11
Bacterial Infections4
Pneumonia4
Pneumonia, Ventilator-Associated2
Respiratory Tract Diseases2
Respiratory Tract Infections2
Atherosclerosis1
Chlamydia Infections1
Community-Acquired Infections1
Cross Infection1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.